SCHOLARSHIPS AWARDED BY ESTEVE TO THE BEST THREE PROJECTS TO IMPROVE CHRONIC PATIENT CARE
With wide experience in the most relevant areas of chronicity, the Company awards the ESTEVE scholarships for Health-Related Innovation in "Chronic Patient Care".
The names of the winners of the 2013 ESTEVE Scholarships for Health-Related Innovation in "Chronic Patient Care" awarded by ESTEVE for the second year running, were revealed this morning. The winners have been chosen among 70 highly innovative projects for the management of non communicable chronic diseases. Three scholarships with a maximum allowance of 10,000 Euros each have been granted, one to each category.
According to the WHO, 80% of the Spanish population will have a non-communicable chronic disease in 2020, thus posing a tremendous burden to healthcare systems and their sustainability. Under this scenario, self innovation by health providers is indispensable to effectively tackle the challenge of chronicity. That is why these scholarships are intended to help improve the chronic patient's quality of life, promote healthy lifestyle habits, and prevent chronic diseases. In parallel, they are also meant to foster innovation among healthcare providers, as well as encourage participation among the system's different actors and levels, and promote research, training and chronicity knowledge management.
This successful second edition of ESTEVE Scholarships has received 70 projects from 11 Autonomous Communities. In one of the following three categories: Low Complexity Chronic Patients (48%), Medium Complexity Chronic Patients (26%), and High Complexity Chronic Patients (26%). Healthcare providers from 23 different specialties have participated, both on an individual and group basis, led by Primary Care and Nursing, and followed by Internal Medicine, Hospital Pharmacy, Endocrinology, Psychology, Research, Geriatrics, Orthopedic Surgery, Cardiology, Vascular Surgery, Physiotherapy, Pneumology, Neurology, Oncology and Psychiatry, among others.
Scholarships awarded to innovation in chronic patient care
In the High Complexity Chronic Patient category, the scholarship has been awarded to the project submitted by the Marqués de Valdecilla IFIMAV Institute for Training and Research of Mortera (Cantabria). Under the name "A new healthcare model for complex patient care in Cantabria: the PREVICA Program" and led by Dr. Manuel Francisco Fernández Miera, this project is part of the Regional Strategy for Chronic Patient Care currently being designed and to be implemented in the public healthcare system of Cantabria. This project consists of action conducted prior to the PREVICA Program, where the design and organization of a training schedule is brought up to health and social care providers addressing complex chronic patients with multiple diseases, and also involving the creation and validation of a sound stratification model allowing to better identify patients who need to be included in the PREVICA Program.
The project led by Dr. Florentino Carral San Laureano, from the Endocrinology and Nutrition Service of the University Hospital Puerta Real of San Fernando (Cádiz) has won the scholarship awarded to the Medium Complexity Chronic Patient category. The main purpose of "An evaluation of the effectiveness and efficiency of telemedicine in diabetes mellitus care" is to evaluate the effectiveness of telecare ―developed jointly by physicians and nurses― on the metabolic control of diabetic patients, as well as its impact on direct costs related to in-person visits to primary care centers, specialized physicians, and Emergencies. This will be evaluated in three groups of patients, i.e. having diabetes type 1, diabetes type 2, or gestational (pregnancy-related) diabetes.
In the Low Complexity Chronic Patient category, the scholarship has been awarded to the Raval Nord Primary Care Team (PCT) of Barcelona, led by Josep Mª Segura Noguera. The project "Effectiveness of a multifactorial intervention for the modification of fragility parameters in the elderly: The Fragility Study" will allow evaluating the effectiveness of multifactorial intervention based on physical activity, diet, memory workshops and medication review in order to modify the parameters of fragility, muscle strength, and physical and cognitive performance in people aged 65 years and older who find themselves in vulnerable situations at risk of independence loss. This project will include a clinical trial to be conducted by 8 Primary Care Teams of two Barcelona districts with a greater percentage of aging and over aging people as compared to the rest of the city.
The jury, formed by the members of the Scientific Committee of the V Congress of Chronic Patient Care, has chosen the winners of the 2013 ESTEVE Scholarships for Health-Related Innovation on the basis of innovation, scientific and technical quality, viability and applicability in other areas or territories, as well as teamwork and multidisciplinary collaboration in the projects encouragement.
You may follow ESTEVE at Twitter link twitter.com/esteve_news.
THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’
Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...read more
PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES
Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...read more
ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER
ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...read more